CoreAge Rx vs FMmeds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and FMmeds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 80 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make FMmeds a bad call — it's best for readers who want a named pharmacy and can confirm the full membership payment schedule before committing. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | FMmeds |
|---|---|---|
| Brief Score | 94/100 (A) | 80/100 (B−) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm plan and billing period Compounded semaglutide/B12 starts at $95; full commitment and upfront payment unconfirmed. Terms use a 28-day membership cycle. Full price detailsCompounded semaglutide with B12 offered; complete current commitment and billing quote unknown; starting figure $95; earlier listing: From $225/mo (all doses, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm plan and billing period Compounded tirzepatide/B12 starts at $145; full commitment and upfront payment unconfirmed. Terms use a 28-day membership cycle. Full price detailsCompounded tirzepatide with B12 offered; complete current commitment and billing quote unknown; starting figure $145; earlier listing: From $265/mo (all doses, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises all 50 states plus DC; confirm clinician and prescription eligibility in your location |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
FMmeds: Advertised starts are $95 semaglutide/$145 tirzepatide; full plan term and payment schedule unconfirmed. Terms describe a 28-day membership cycle.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.